9-MW-4113

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug Name9-MW-4113
Drug Alias Name9MW41139-MW-4113
ClassificationBiologics > Biosimilar
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPrurigo NodularisDermatitis, AtopicPulmonary Disease, Chronic Obstructive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesMabwell (Shanghai) Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMabwell (Shanghai) Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsPrurigo NodularisDermatitis, AtopicPulmonary Disease, Chronic Obstructive +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A